LOW-VOLUME · HOSP-MID
terbinafine Side Effects
terbinafine (also sold as Lamisil) is a LOW-VOLUME FAERS extract #365 of 524 by FAERS report count. Still opens on HOSP-MID: 27.0% mention hospitalization (1,849 reports).
Data updated 2026-05-15
- 6,848
- FAERS reports
Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.
terbinafine: 27.0% mention hospitalization (1,849 reports). Death stamp DEATH-HEAVY; volume band LOW-VOLUME #365 of 524 by FAERS report count.
Thinner FAERS extract for terbinafine (Lamisil) (6,848 reports #365 of 524 by FAERS report count). 27.0% mention hospitalization (1,849 reports). Sparse books still carry named reaction rows when present; not medical advice.
Counts from the openFDA FAERS extract (2003–2025). Stamps WATCHLIST · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
RASH leads 391 of 6,848 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (1,917 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (428 reports, 6.3%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 76 |
| SCEDOSPORIUM INFECTION | 37 |
| ACUTE KIDNEY INJURY | 29 |
| MULTIPLE ORGAN DYSFUNCTION SYNDROME | 29 |
| RENAL FAILURE | 27 |
| CONDITION AGGRAVATED | 25 |
| DISEASE PROGRESSION | 25 |
| DRUG INEFFECTIVE FOR UNAPPROVED INDICATION | 23 |
| SEPTIC SHOCK | 23 |
| RESPIRATORY FAILURE | 22 |
| FUNGAEMIA | 17 |
| DRUG RESISTANCE | 16 |
| PNEUMONIA | 16 |
| PYREXIA | 16 |
| CARDIAC ARREST | 15 |
| CHRONIC KIDNEY DISEASE | 15 |
| INFECTION | 14 |
Reactions in Hospitalization Reports
Hospitalization mid-share (1,849, 27.0%). Co-reported reactions:
| Reaction | Reports |
|---|---|
| ACUTE KIDNEY INJURY | 100 |
| DRUG INTERACTION | 97 |
| ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS | 93 |
| RASH | 91 |
| PAIN | 90 |
| DYSPNOEA | 88 |
| FATIGUE | 85 |
| PYREXIA | 83 |
| MALAISE | 81 |
| PRURITUS | 81 |
| NAUSEA | 67 |
| PNEUMONIA | 64 |
| ABDOMINAL PAIN | 63 |
| RENAL FAILURE | 60 |
| ANXIETY | 59 |
| COUGH | 57 |
| VOMITING | 57 |
| DIARRHOEA | 56 |
How to read terbinafine FAERS figures (WATCHLIST · DEATH-HEAVY · HOSP-MID)
FAERS holds 6,848 voluntary reports linked to terbinafine (Lamisil), 2003-2025. Death is listed on 428 (6.3%). Hospitalization appears on 1,849 (27.0%). Top co-reported indication: Product Used For Unknown Indication.
Sparse extract - named reactions and SEX-BALANCED skew still differ by drug; not a complete safety profile.
Read with terbinafine
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-MID stamps.
ABS(total_reports) peer at 6,862 FAERS cases (Δ 14 heavier vs terbinafine); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 6,775 FAERS cases (Δ 73 lighter vs terbinafine); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 6,989 FAERS cases (Δ 141 heavier vs terbinafine); DEATH-MARKED · HOSP-LIGHT · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 7,061 FAERS cases (Δ 213 heavier vs terbinafine); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 55.9 pp vs terbinafine's DEATH-HEAVY): CASELOAD · HOSP-MID.
terbinafine stamps DEATH-HEAVY · HOSP-MID; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload WATCHLIST and the label guide.